Search Results - "Buhlinger, Kaitlyn"

Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients by Buhlinger, Kaitlyn M, Fuller, Kathryn A, Faircloth, Cassidy B, Wallace, Jessica R

“…PURPOSE.Results of a study of rates of acute kidney injury (AKI) in pediatric patients treated with vancomycin plus piperacillin-tazobactam or vancomycin plus…”
Get full text

Outpatient initiation of venetoclax in patients with acute myeloid leukemia by Palmer, Shannon, Patel, Anand, Wang, Christopher, Patel, Bianka, Zeidner, Joshua, Foster, Matthew, Muluneh, Benyam, Buhlinger, Kaitlyn

“…Introduction Venetoclax is a treatment option in patients with acute myeloid leukemia (AML) in both the front-line and relapsed/refractory settings. Initiation…”
Get full text

Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia by Shinn, Lauren T., Benitez, Lydia L., Perissinotti, Anthony J., Reid, Justin H., Buhlinger, Kaitlyn M., van Deventer, Hendrik, Barth, Dylan, Wagner, Charlotte B., Zacholski, Kyle, Desai, Ruchi, Soule, Ashley, Stump, Sarah E., Weis, Taylor M., Bixby, Dale, Burke, Patrick, Pettit, Kristen, Marini, Bernard L.

“…Eltrombopag has been shown to improve response rates when added to standard therapy in adults with severe aplastic anemia in controlled trial settings…”
Get full text

Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia by Ochs, Madeleine A., Marini, Bernard L., Benitez, Lydia L., Stump, Sarah E., Weis, Taylor M., Buhlinger, Kaitlyn M., Diaz, Thomas, Reid, Justin H., Muluneh, Benyam, Pettit, Kristen, Burke, Patrick, Bixby, Dale L., Perissinotti, Anthony J.

“…Patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) represent a heterogeneous population and therefore there is no standard of care…”
Get full text

Effects of Dicloxacillin on Warfarin Dose in Patients With a Left Ventricular Assist Device by Buhlinger, Kaitlyn M., Hollis, Ian B.

“…Patients with a durable, continuous flow left ventricular assist device (CF-LVAD) require anticoagulation with warfarin to prevent thromboembolic events…”
Get full text

Identifying Shared Values for School-Affiliated Student Organizations by Bush, Antonio A., Buhlinger, Kaitlyn M., McLaughlin, Jacqueline E.

“…Objective. To identify shared values for student organizations. Methods. A three-round Delphi approach was utilized to identify and prioritize shared values…”
Get full text

Processes and perceptions of chemotherapy supply chain in Ethiopia: A mixed-method study by Stocker, Kurtis J, Tiemann, Andrew, Brunk, Kelly M, Agegnehu, Bemnat, Buhlinger, Kaitlyn, Amerine, Lindsey, Roberts, Megan C, McLaughlin, Jacqueline E, Clark, Stephen M, Rose, Robert, Mekonnen, Befikadu, Bhakta, Nickhill, Fentie, Atalay Mulu, Alexander, Thomas B, Ozawa, Sachiko, Chargualaf, Michael, Muluneh, Benyam

“…Background The impact and downstream effects of the chemotherapy supply chain in Ethiopia are not well understood. The purpose of this study was to identify…”
Get full text

Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics by Palmer, Shannon, Chen, Ashley, Dennison, Taylor, Czech, Cameron, Auten, Jessica, Buhlinger, Kaitlyn, Muluneh, Benyam

“…Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient…”
Get full text

Results of a pre-implementation analysis of Ethiopia’s National Pediatric Cancer Registry by Buhlinger, Kaitlyn M, Borlagdan, Jared, Agegnehu, Bemnat, Fentie, Atalay M, Bernstein, Adam T, Urick, Benjamin Y, Roberts, Megan, Weitzman, Sheila, Bekele, Wondwessen, Korones, David, Alexander, Thomas B, Broas, Julie, Shad, Aziza, Dinkiye, Ali Mamude, Clark, Stephen M, Adam, Hayleyesus, Hailu, Daniel, Muluneh, Benyam

“…In Ethiopia, cancer accounts for about 5.8% of total national mortality, with an estimated annual incidence of cancer of approximately 60,960 cases and an…”
Get full text

Pharmacists' Role in Managing Patients with Chronic Lymphocytic Leukemia by Chen, Kevin Y, Brunk, Kelly M, Patel, Bianka A, Stocker, Kurtis J, Auten, Jessica J, Buhlinger, Kaitlyn M, Muluneh, Benyam

“…Chronic lymphocytic leukemia (CLL) is a hematologic malignancy that has seen significant advances in care over the last 5 years with the approval of oral…”
Get full text

Pre-implementation assessment of a national Ethiopian pediatric cancer registry by Mulu Fentie, Atalay, Buhlinger, Kaitlyn, Borlagdan, Jared, Bernstein, Adam, Weitzman, Sheila, Bekele, Wondwessen, Korones, David, Alexander, Thomas B., Broas, Julie, Shad, Aziza, Mamude Dinkiye, Ali, Hailu, Daniel, Muluneh, Benyam

Get full text

Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML by Bryant, Ashley Leak, Buhlinger, Kaitlyn

“…Recent advances have resulted in an expansion of treatment options for AML, especially targeted therapies and low-intensity regimens. At JADPRO Live Virtual…”
Get full text

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium by Benitez, Lydia, Marx, Kayleigh R., Buhlinger, Kaitlyn M., Clark, Stephen M., Reid, Justin H., Rausch, Caitlin R, Gatwood, Katie S, Stump, Sarah E., Shah, Richa, Ciervo, Jenna, Baron, Jeffrey, Marini, Bernard Lawrence, Perissinotti, Anthony J., Waldron, Madeline, Muluneh, Benyam

“…Background: Regimens employing all-trans retinoid acid and arsenic (ATRA+ATO) are the backbone of high-risk APL treatment. The APML4 regimen consists of a…”
Get full text

Evaluation of an interdisciplinary venetoclax initiation process in minimizing risk of tumor lysis syndrome by Cozad, Monica, Stump, Sarah E., Buhlinger, Kaitlyn, Collins, James, Muir, Michele, Coombs, Catherine C., Muluneh, Benyam

“…Venetoclax is a BCL-2 inhibitor approved for treatment of adult patients with chronic lymphocytic leukemia (CLL). Due to significant risk of tumor lysis…”
Get full text

Pharmacist-facilitated Patient Reported Outcome Measure (PROM) monitoring: developing an EHR SmartForm© to monitor side effects of oral oncolytics during routine telehealth encounters by Stover, Angela M, Liang, Debbie, Mueller, Dana, Kurtzman, Rachel, Ikemeh, Christiana, Canter, Courtney, Acharya, Sonali, Brese, Jill, Buhlinger, Kaitlyn, Chen, Kevin, Colmenares, Evan W, Faso, Aimee, Muluneh, Benyam, Patel, Bianka, Reichard, Jeffrey S, Shah, Rushabh M, Tilkens, Michael, Valgus, John, Coombs, Lorinda A, Lafata, Jennifer Elston, Lund, Jennifer L, Ray, Emily M, Mody, Gita, Vest, Mary-Haston

“…Patient reported outcome measures (PROMs) are increasingly used in oncology care, but pharmacists providing direct patient care have been overlooked. We…”
Get full text

Chemotherapy safe handling practices in Ethiopia: A comprehensive multi-center evaluation by Webb, Nathaniel, Matys, Samantha, Collins, James B, Garcia, Julian, Worku, Kaleab, Lines, Mandee, Hirata, Hailey, Dark, Erin, Brooks, Callee, Buhlinger, Kaitlyn, Fentie, Atalay Mulu, Roberts, Megan C, Muluneh, Benyam

“…The increasing incidence of cancer and capacity for cancer care in Ethiopia has led to an upsurge in chemotherapy use in the country; however, studies indicate…”
Get full text

Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase by Chen, YeeAnn, Buhlinger, Kaitlyn, Perissinotti, Anthony J., Schepers, Allison J., Benitez, Lydia, Auten, Jessica, Chen, Sheh-Li, Bixby, Dale L., Burke, Patrick W., Pettit, Kristen M., Marini, Bernard L.

“…PEG-asparaginase is a key component in treatment regimens for acute lymphoblastic leukemia (ALL). Major side effects include thrombosis and bleeding; however,…”
Get full text

Ethiopian paediatric oncology registry progress report: documentation practice improvements at tertiary care centre in Addis Ababa, Ethiopia by Levy, Scott, Fentie, Atalay Mulu, Buhlinger, Kaitlyn, Clark, Stephen M, Korones, David N, Miller, Vanessa, Alexander, Thomas B, Weitzman, Sheila, Bekele, Wondwessen, Broas, Julie, Shad, Aziza, Roberts, Megan, Chargualaf, Michael, Fufa, Diriba, Hailu, Tadele, Yimer, Mulugeta Ayalew, Mustefa, Mohammed, Said Gidey, Abdulkadir M, Dinkiye, Ali Mamude, Adam, Haileyesus, Hailu, Daniel, Muluneh, Benyam

“…Building on our previous work, we sought to standardise patient treatment documentation within the paediatric haematology and oncology department at Tikur…”
Get full text

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment by Ramkissoon, Lori A., Buhlinger, Kaitlyn, Nichols, Angela, Coombs, Catherine C., Foster, Matthew C., Galeotti, Jonathan, Kaiser-Rogers, Kathleen, Richardson, Daniel R., Montgomery, Nathan D., Zeidner, Joshua F.

Get full text

A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML by Muluneh, Benyam, Buhlinger, Kaitlyn, Deal, Allison M., Zeidner, Joshua F., Foster, Matthew C., Jamieson, Katarzyna Joanna, Bates, Jill, Van Deventer, Hendrik W.

“…The data for savage regimens in relapsed/refractory AML is largely based on phase 2, single arm studies and comparative data is scarce. The purpose of this…”
Get full text